REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Identification Or Warning Feature Identification Or Warning FeatureIdentification Or Warning Feature patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.06/07/07 - 20070128121 - Polymer hydrogels for controlled release and absorption of biocides A material that is capable of releasing an active agent in a controlled manner. The material includes a hydrogel vehicle and an active agent dispersed throughout the hydrogel. When brought into contact with an aqueous release media, the active agent is released from the hydrogel vehicle into the release media. ... 05/31/07 - 20070122348 - Opioid agonist/antagonist combinations The invention is directed in part to oral dosage forms comprising a combination of an orally analgesically effective amount of an opioid agonist and an orally active opioid antagonist, the opioid antagonist being included in a ratio to the opioid agonist to provide a combination product which is analgesically effective ... 04/26/07 - 20070092451 - Time indicating containers for dental compositions A system for storing a dental composition having a given shelf-life. The storage system includes a container (e.g., a syringe) and activatable time sensitive marking means disposed on or within the container. Upon activation of the time sensitive marking means, the system begins to indicate time lapsed since activation. The ... 03/22/07 - 20070065365 - Abuse-resistant transdermal system An abuse-resistant transdermal system which contains, in addition to one or more active ingredients with potential for abuse, at least one gel-forming agent in quantities such that it forms a gel with a minimum quantity of an aqueous liquid, and contains as further agents which complicate or prevent abuse at ... 03/22/07 - 20070065364 - Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same The present invention relates to co-extruded pharmaceutical compositions and dosage forms comprising an adverse agent, such as an opioid antagonist, which can be sequestered. The pharmaceutical compositions and dosage forms diversion of a dosage form containing an active pharmaceutical agent, such as an opioid. The present invention also relates to ... 03/01/07 - 20070048228 - Abuse-proofed dosage form The invention relates to a dosage form that is thermoformed without discoloration and is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of at least 500 N in addition to one or more active substances that could be subject to abuse. The invention ... 09/21/06 - 20060210480 - Treatment of reduction of dysphagia The present invention provides methods of treating or reducing dysphagia in patients. In one aspect of the invention, such method comprises administering to a patient in need of such treatment or reduction an amount of an agent sufficient to produce a therapeutically effective aversive taste response. In other aspects, such ... 08/31/06 - 20060193782 - Abuse-proofed dosage form The invention relates to a form of administration which is secured against misuse and which is thermoformed without extrusion, including at least one synthetic or natural polymer having a resistance to breaking of at least 500 N in addition to one or several active ingredients with a misuse potential and, ... 08/24/06 - 20060188447 - Process for the production of an abuse-proofed dosage form The present invention relates to a process for the production of an abuse-proofed dosage form containing, apart from one or more active ingredients with potential for abuse and optionally physiologically acceptable auxiliary substances, at least one synthetic or natural polymer (C) with a breaking strength of at least 500 N, ... 08/17/06 - 20060182688 - Metronidazole-based tinted topical pharmaceutical compositions Topically applicable pharmaceutical compositions suited for the treatment of dermatological complaints, conditions or afflictions, notably rosacea, contain a thus effective amount of metronidazole and at least one dye effective to impart a green color thereto, formulated into a topically applicable, pharmaceutically acceptable vehicle therefor. ... 08/10/06 - 20060177381 - Opiopathies The present invention provides novel methods for classifying, diagnosing and/or treating a group of human and veterinary ailments involving endogenous opioid concentrations. Also provided is a novel use for an existing class of compounds, the opioids, to treat opiopathic ailments, particularly paresis/paralysis, pseudo-atrophy and/or opiopathic pain, and in the manufacture ... 08/10/06 - 20060177380 - Methods and compositions for deterring abuse of orally administered pharmaceutical products This invention relates to an abuse deterrent formulation of an oral dosage form of a therapeutically effective amount of any active drug substance that can be subject to abuse combined with a gel forming polymer, a nasal mucosal irritating surfactant and a flushing agent. Such a dosage form is intended ... 07/27/06 - 20060165602 - Method for deterring abuse of opioids by combination with non-release formulation of emetic The present invention pertains to a pharmaceutical dosage form comprising an opioid and a sequestered emetic. When abuse is attempted by crushing, chewing, or otherwise compromising the sequestration, sufficient emetic is released to cause emesis. ... 03/23/06 - 20060062734 - Methods and systems for preventing diversion of prescription drugs The subject invention provides systems and methods for monitoring prescription medications. In particular, systems and methods are provided for monitoring patient compliance with a given prescribed regimen as well as monitoring the origins of a prescription drug. The subject invention provides a central computer and a portable device, wherein the ... 03/23/06 - 20060062733 - Medicament/dosimeter combination packaging In a system for individual dosing of a medicament, in accordance with the individual pathological properties (“fingerprint”) of a patient—corresponding physiologically or genetically to the disease status—two components are provided: a medicament that is to be taken or administered in a variable individual dosage and a miniaturized indicator system that ... 01/12/06 - 20060008418 - Packaging and method for solid dose administration of an electronic identification chip and medicaments A method and packaging for both vaccinating and identifying an animal by implanting a solid dose medicament and an identifying electronic microchip in an animal. The solid dose medicament, or plurality of such medicaments, are each, preferably color-coded to identify a particular active ingredient, then packaged in a pellet magazine ... 01/05/06 - 20060002860 - Abuse-proofed oral dosage form The present invention relates to an abuse-proofed, oral dosage form with controlled opioid-release for once daily administration, characterised in that it comprises at least one opioid with potential for abuse (A), at least one synthetic or natural polymer (C), optionally delayed-release matrix auxiliary substances, physiologically acceptable auxiliary substances (B), optionally ... 01/05/06 - 20060002859 - Process for production of an abuse-proofed solid dosage form The present invention relates to a process for the production of an abuse-proofed solid dosage form containing at least one active ingredient with potential for abuse and a synthetic or natural polymer with a breaking strength of =500 N, characterised in that a corresponding mixture is processed by melt extrusion ... 12/22/05 - 20050281748 - Abuse-deterrent drug formulations An abuse-deterrent pharmaceutical composition has been developed to reduce the likelihood of improper administration of drugs, especially drugs such as opiods. In the preferred embodiment, the drug is modified to increase its lipophilicity by forming a salt between the drug and one or more fatty acids wherein the concentration of ... 12/08/05 - 20050271595 - Sanitizing composition and method of preparation The invention provides a sanitizing composition in the form of a viscous liquid or gel suitable for use as a handwash composition comprising alcohol, water and a thickener wherein the viscous liquid or gel has particles suspended therein, wherein said particles provide the composition with a granular texture and are ... 12/08/05 - 20050271594 - Abuse resistent pharmaceutical composition An abuse-resistant pharmaceutical composition includes an oily substance, at least one active ingredient having abuse potential and a capsule. The active ingredient is mixed in the oily substance. The oily substance and the active ingredient are placed in the capsule. In one embodiment the active ingredient includes oxicodone. ... 10/06/05 - 20050220715 - Methods and compositions for improving drug safety A pharmaceutical composition with improved safety includes a selected amount of a vomit-inducing agent, wherein the selected amount is less than an amount needed to induce vomit in a user; and a therapeutic agent. The therapeutic agent may be selected from a sleeping pill, an anxiolytic, a hypnotic, a contraceptive ... 09/29/05 - 20050214223 - Abuse-safeguarded dosage form A pharmaceutical dosage form that is safeguarded against abuse containing at least one active substance that is susceptible to abuse and at least two of the following constituents (a) through (d): (a) at least one substance that irritates the nasal and/or pharyngeal region; (b) at least one viscosity increasing agent ... 07/21/05 - 20050158246 - Capsule medication administration system, and medication administration method A capsule medication administration system includes: a first capsule for internal body marking; a second capsule for medication; a marking device which makes a marking within a living body; a drug retention section which retains a drug; a release device which releases the drug; a detection device which detects the ... 07/14/05 - 20050152843 - Abuse-proofed dosage form The invention relates to a solid administration form, protected from parenteral abuse and containing at least one viscosity-increasing agent in addition to one or more active substances that have parenteral abuse potential. The agent forms, when a necessary minimum amount of an aqueous liquid is added, on the basis of ... ### FreshPatents.com Support |